CRANBURY, N.J., Oct. 27, 2011 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare diseases, today announced a conference call and live audio webcast on Tuesday, November 1, 2011 at 5 p.m. ET to discuss financial results for the third quarter ended September 30, 2011.
